(Q36811485)

16 August 2017

1 reference

title

Hepatosplenic T-cell lymphoma in adolescents and young adults with Crohn's disease: a cautionary tale? (English)

1 reference

hepatosplenic T-cell lymphoma

16 August 2017

0 references

1 reference

1 reference

4

Anne Griffiths

1 reference

16 August 2017

Joel R Rosh

1

1 reference

16 August 2017

Thomas Gross

series ordinal

2

1 reference

16 August 2017

Petar Mamula

series ordinal

3

1 reference

16 August 2017

Jeffrey Hyams

series ordinal

5

1 reference

16 August 2017

1 August 2007

1 reference

Inflammatory Bowel Diseases

16 August 2017

1 reference

16 August 2017

13

1 reference

16 August 2017

1024-1030

1 reference

16 August 2017

8

1 reference

A cost-effectiveness analysis of alternative disease management strategies in patients with Crohn's disease treated with azathioprine or 6-mercaptopurine

16 August 2017

1 reference

The incidence of lymphoid and myeloid malignancies among hospitalized Crohn's disease patients

21 January 2018

1 reference

Extracolonic malignancies in inflammatory bowel disease.

21 January 2018

1 reference

Risk of haematopoietic cancer in patients with inflammatory bowel disease

21 January 2018

1 reference

Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine

21 January 2018

1 reference

Treatment with biologic therapies and the risk of cancer in patients with IBD.

21 January 2018

1 reference

Infliximab and newly diagnosed neoplasia in Crohn's disease: a multicentre matched pair study

21 January 2018

1 reference

The serine protease granzyme M is preferentially expressed in NK-cell, gamma delta T-cell, and intestinal T-cell lymphomas: evidence of origin from lymphocytes involved in innate immunity

21 January 2018

1 reference

Hepatosplenic alphabeta T-cell lymphomas: a report of 14 cases and comparison with hepatosplenic gammadelta T-cell lymphomas

21 January 2018

1 reference

Allogeneic bone marrow transplantation for chemotherapy-refractory hepatosplenic gammadelta T-cell lymphoma: case report and review of the literature

21 January 2018

1 reference

Hepatosplenic gammadelta T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients

21 January 2018

1 reference

Hepatosplenic T cell lymphoma. A review on 45 cases since the first report describing the disease as a distinct lymphoma entity in 1990.

21 January 2018

1 reference

Hepatosplenic T-cell lymphoma in an adolescent patient after immunomodulator and biologic therapy for Crohn disease

21 January 2018

1 reference

Hepatosplenic T-gammadelta lymphoma in a patient with Crohn's disease treated with azathioprine

21 January 2018

1 reference

Non-Hodgkin's lymphoma in childhood

21 January 2018

1 reference

Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease

21 January 2018

1 reference

A randomized, double-blind, placebo-controlled trial of CDP571, a humanized monoclonal antibody to tumour necrosis factor-alpha, in patients with corticosteroid-dependent Crohn's disease

21 January 2018

1 reference

Incidence and importance of antibody responses to infliximab after maintenance or episodic treatment in Crohn's disease.

21 January 2018

1 reference

Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial

21 January 2018

1 reference

The hepatitis C envelope 2 protein inhibits LFA-1-transduced protein kinase C signaling for T-lymphocyte migration

21 January 2018

1 reference

Intravenous hydrocortisone premedication reduces antibodies to infliximab in Crohn's disease: a randomized controlled trial

21 January 2018

1 reference

Workshop report: prevention of postoperative recurrence in Crohn's disease.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IBD.20169

1 reference

16 August 2017

1 reference